Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:
“The Colorectal Cancer Alliance congratulates Emil Lou, who is being honored by TIME at a gala event this week.
Dr. Lou was named to the 2026 TIME 100 Health List of the World’s Most Influential Leaders in Health. A well-deserved recognition for an extraordinary researcher who is reshaping the future of colorectal cancer care.
We are honored to work alongside Dr. Lou on our Project Cure CRC initiative, in which he is actively involved in driving progress and pathways to improve CRC treatments and patient care.
Dr. Lou’s research is advancing precision oncology approaches that move us closer to real, durable cures for colorectal cancer. His work, including remarkable findings in CRC immunotherapy treatment published in The Lancet Group, reflects a shift our field urgently needs, from incremental progress to transformational outcomes.
Recognition like this signals something larger than an individual achievement. It signals momentum and shines a spotlight on much-needed smarter science, deeper collaboration, and measurable impact in the CRC space.
We are proud to partner with leaders who are not only advancing research, but redefining what is possible in colorectal cancer care.”
Other articles featuring Michael Sapienza on OncoDaily.